MOLLY WYANT: Open Payments
NPI 1366602500 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,073 in 58 payments from 19 companies in 2025. Trend: 2023 $1,134 · 2024 $899 · 2025 $1,073
Food & beverage: $1,073
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $255 |
| Janssen Biotech, Inc. | 7 | $158 |
| Ipsen Biopharmaceuticals, Inc | 4 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| PFIZER INC. | 4 | $70 |
| Ardelyx, Inc. | 2 | $60 |
| Madrigal Pharmaceuticals | 2 | $49 |
| QOL Medical, LLC | 2 | $43 |
| Lilly USA, LLC | 2 | $38 |
| Intercept Pharmaceuticals, Inc. | 2 | $35 |
Products named: TREMFYA, RINVOQ, IQIRVO, LINZESS, ENTYVIO, IBSRELA, SKYRIZI, REZDIFFRA.
Industry payments across AZ — which companies pay providers there.
